重症RSウイルス患者における危険因子および分子遺伝子型研究
重症RSウイルス患者における危険因子および分子遺伝子型研究
批准号:
15F15116
负责人:
吉田 レイミント
金额:
$1.47万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for JSPS Fellows
财政年份:
2015
资助国家:
日本
项目状态:
已结题
起止时间:
2015-04-24 至 2017-03-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
To investigate the clinical relevance of RSV-A ON1,acute respiratory infection (ARI) cases enrolled to our population-based prospective pediatric ARI surveillance at Khanh Hoa General Hospital, Central Vietnam from January 2010 through December 2012 were studied. Clinical-epidemiological information and nasopharyngeal samples were collected. Multiplex PCR assays were performed for screening 13 respiratory viruses. RSVpositive samples were further tested for subgroups (A/B) and genotypes information by sequencing the G-glycoprotein 2nd hypervariable region. Statistical analysis was performed to evaluate the clinicalepidemiological characteristics of RSV-A ON1. The study demonstrated the clinical relevance of RSV-A ON1 infected ARI cases. Respiratory viruses were detected in 66.2% of the cases, in which RSV (n = 426, 23.0%), Influenza (12.0%) and Rhinovirus (25.1%) were the leading respiratory viruses detected. RSV-positive cases were significantly younger, wheezing (52.8%), tachypnea (31.0%), crackle (21.6%) and chest-wall indrawing (9.9%) were significantly more common. In this study, 123 RSV-A ON1 and 138 NA1 were genotyped. ON1 cases were younger, frequently associated with underlying medical condition and respiratory sign and symptoms such as wheeze (81.3%), tachypnea (50.4%) and difficulty in breathing (18.7%). In addition, ARI cases with LRTI (34.2%) and radiologically-confirmed pneumonia (19.5%) were more commonly seen in ON1 ARI cases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1038/srep27856
发表时间:
2016-06-16
期刊:
Scientific reports
影响因子:
4.6
作者:
[Yoshihara K, Le MN, Okamoto M, Wadagni AC, Nguyen HA, Toizumi M, Pham E, Suzuki M, Nguyen AT, Oshitani H, Ariyoshi K, Moriuchi H, Hashizume M, Dang DA, Yoshida LM]
通讯作者:
Yoshida LM
NIHE/Khanh Hoa General Hospital(ベトナム)
NIHE/庆和综合医院(越南)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Molecular epidemiology, antiviral resistant variants and therapeutic options of hepatitis B and C in Nigeria
-
批准号:22KK0147
-
项目类别:Fund for the Promotion of Joint International Research (Fostering Joint International Research (B))
-
资助金额:$12.81万
-
财政年份:2022
-
负责人:吉田 レイミント
-
依托单位:
国内基金
海外基金
救治呼吸衰竭新方法及脉冲放电治疗仪的研究
-
批准号:50347009
-
项目类别:专项基金项目
-
资助金额:10.0万元
-
批准年份:2003
-
负责人:李劲
-
依托单位: